ArticleCureus2025
Correlation of Internal Echo Findings With the Aggressiveness of Diffuse Large B-Cell Lymphomas: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
It is well known that diffuse large B-cell lymphomas (DLBCLs) generally have very low internal echoes. We herein report a case of DLBCL presenting with internal high echoes and found that internal high echoes correlate with the less aggressive form of the tumor. A 68-year-old man with a history of sigmoid colon cancer and metastatic liver tumor surgeries was referred to our hospital due to multiple swollen lymph nodes, especially around the abdominal aorta. Positron emission tomography/computed tomography of the target foci showed a maximum standardized uptake value of 23. The soluble interleukin-2 receptor was elevated up to 2763 U/mL. Ultrasound showed that the masses predominantly had internal low echoes; however, there were some masses with punctate internal high echoes in the upper abdomen and these seemed most amenable to surgical removal. The patient, therefore, underwent an excisional biopsy on one of these target nodes. Pathological study of the removed node showed medium-to-large atypical cells diffusely proliferating against mixed sclerotic and edematous backgrounds. In addition, the mass had heterogeneous dense and sparse areas of atypical cells. Immunostaining of the atypical cells showed CD20, CD79a, CD5, and BCL2 positivity, CD10, CD15, CD23, CD30, BCL6, and cyclin D1 negativity, and a Ki-67 labelling index of 70%, leading to the diagnosis of DLBCL. Diagnostic physicians should note that DLBCLs can have internal high echoes when having sparse lymphoma cells against the edematous background.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.